Evaluating the nutritional status of a lung cancer patient is an important element in patient management;L'évaluation du statut nutritionnel du patient suivi pour un cancer bronchique est un élément important de la prise en charge

Revue de Pneumologie Clinique

Volumn 64, Issue 2, 2008, Pages 92-98

  Antoun, S ^a   Merad, M ^a   Raynard, B ^a   Ruffie, P ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Enteral nutrition; Lung cancer; Malnutrition; Omega 3 fatty acid; Oral nutritional support; Parenteral nutrition

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; MEGESTROL ACETATE; OMEGA 3 FATTY ACID;

ANOREXIA; ARTIFICIAL FEEDING; CACHEXIA; CANCER STAGING; CANCER SURVIVAL; CULTURAL FACTOR; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE SEVERITY; ENTERIC FEEDING; FOOD COMPOSITION; GASTROINTESTINAL SURGERY; GASTROINTESTINAL TRACT FUNCTION; GOOD CLINICAL PRACTICE; HUMAN; LUNG CANCER; MALABSORPTION; MALNUTRITION; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL SOCIETY; MORBIDITY; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; NUTRITIONAL VALUE; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PREOPERATIVE PERIOD; PRESCRIPTION; REVIEW; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; CACHEXIA; ENTERAL NUTRITION; FATTY ACIDS, OMEGA-3; HUMANS; LUNG NEOPLASMS; NUTRITIONAL STATUS; PALLIATIVE CARE; PATIENT CARE TEAM; PROTEIN-ENERGY MALNUTRITION; SURVIVAL RATE;

EID: 68649117879     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneumo.2008.03.002     Document Type: Review

References (35)

1. Kruizenga H.M., Wierdsma N.J., Van Bokhorst M.A.E., Van Der Schueren D.E., Hollander H.J., Jonkers-Schuitema C.F., et al. Screening of nutritional status in the Netherlands. Clin Nutr 22 (2003) 147-152
2. Dewys W.D., Begg C., Lavin P.T., Band P.R., Bennett J.M., Bertino J.R., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69 (1980) 491-497
3. Jagoe R.T., Goodship T.H.J., and Gibson G.J. Nutritional status of patients undergoing lung cancer operations. Ann Thorac Surg 71 (2001) 929-935
4. Win T., Ritchie A.J., Wells F.C., and Laroche C.M. The incidence and impact of low body mass index on patients with operable lung cancer. Clin Nutr 26 (2007) 440-443
5. Tewari N., Martin-Ucar A.E., Black E., Beggs L., Beggs F.D., Duffy J.P., et al. Nutritional status affects long-term survival after lobectomy for lung cancer. Lung Cancer 57 (2007) 389-394
6. Jeremic B., Milicic B., Dagovic A., Aleksandrovic J., and Nikolic N. Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy. J Cancer Res Clin Oncol 129 (2003) 114-122
7. Ross P.J., Ashley S., Norton A., Priest K., Waters J.S., Eisen T., et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancer?. Br J Cancer 90 (2004) 1905-1911
8. Khalid U., Spiro A., Baldwin C., Sharma B., McCough C., Norman A.R., et al. Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15 (2007) 39-46
9. Unsal D., Mentes B., Akmansu M., Uner A., Oguz M., and Pak Y. Evaluation of nutritional status in cancer patients receiving radiotherapy. Am J Clin Oncol 29 (2006) 183-188
10. Nitenberg G., and Raynard B. Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 34 (2000) 137-168
11. Jatoi A., Daly B.D.T., Hughes V.A., Dallal G.E., Kehayias J., and Roubenoff R. Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure?. Ann Thorac Surg 72 (2001) 348-351
12. Stall-van den Brekel A.J., Schols A.M., Dentener M.A., ten Velde G.P., Buurman W.A., and Wouters E.F. Metabolisme in patients with small cell lung carcinoma compared with non-small cell lung carcinoma and healthy controls. Thorax 52 (1997) 338-341
13. Stall-van den Brekel A.J., Dentener M.A., Schols A.M., Buurman W.A., and Wouters E.F. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer. J Clin Oncol 13 (1995) 2600-2605
14. Frederix E.W.H.M., Stall-van den Brekel A.J., and Wouters E.F. Energy balance in nonsmall cell lung carcinoma patients before and after surgical resection of their tumors. Cancer 79 (1997) 717-723
15. Jebb S.A., Osborne R.J., Dixon A.K., Bleehen N.M., and Elia M. Measurements of resting energy expenditure and body composition before and after treatment of small cell lung cancer. Ann Oncol 5 (1994) 915-919
16. Andreyev H.J.N., Norman A.R., Oates J., and Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies. Eur J Cancer 34 (1998) 503-509
17. Prado C.M.M., Baracos V.E., McCargar L.J., Mourtzakis M., Mulder M., Reiman T., et al. Body composition as an independent determinant of 5-fluorouracil based chemotherapy toxicity. Clin Cancer Res 13 (2007) 3264-3268
18. Alexandre J., Gross-Goupil M., Falissard B., Nguyen M.L., Gornet J.M., Misset J.L., et al. Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy. Ann Ocol 14 (2003) 36-41
19. Sandro M., and Rodrigues P.J. Clinical factors and prognosis in non-small cell lung cancer. Am J Clin Oncol 22 (1999) 453-457
20. Klein S., Kinney J., Jeejeebhoy K., Alpers D., Hellerstein M., Murray M., et al. Nutritionnal support in clinical practice: review of published data and recommendations for future research directions. Clin Nutr 16 (1997) 193-218
21. Weimann A., Braga M., Harsanyi L., Laviano A., Ljungqvist O., and Soeeters P. ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr 25 (2006) 224-244
22. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med 325 (1991) 525-532
23. Armstrong P., Congleton J., Fountain S.W., Jagoe T., McAuley D.F., and MacMahon J. Guidelines on the selection of patients with lung cancer for surgery. Thorax 56 (2001) 89-108
24. Ovesen L, Allingstrup L, Hannibal J, Mortensen EL, Hansen OP. Effect of dietary counselling on food intake, body weight, response rate, survival and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 1993;11:2043-2049.
25. Simons J.P., Aoronson N.K., Vansteenkiste J.F., Ten Velde G.P.M., Muller M.J., Drenth B.M., et al. Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study. J Clin Oncol 14 (1996) 1077-1078
26. Mateen F., and Jatoi A. Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients. Clin Nutr 25 (2006) 711-715
27. Evans W.K., Daly N.J.M., Ellenberger S.S., Gardner L., Wolfe E., Shepherd F.A., et al. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol 5 (1987) 113-124
28. Klein S., and Koretz R.L. Nutrition support in patients with cancer: what do the data really show?. Nutr Clin Pract 9 (1994) 91-100
29. Koretz R.L., Lipman T.O., Klein S., and American Gastroenterological Association. AGA technical review on parenteral nutrition. Gastroenterology 121 (2001) 970-1001
30. Shang E., Weiss C., Post S., and Kaehler G. The influence of early supplementation of parenteral nutrition on quality of life and body composition in patients with advanced cancer. J Parenter Enteral Nutr 30 (2006) 222-230
31. Chlebowski R., Palomares M.R., Lillington L., and Grosvenor M. Recent implications of weight loss in lung cancer management. Nutrition 12 (1996) S43-S47
32. Antoun S., Merad M., Nitenberg G., Ruffié P., and Raynard B. Immuno nutrition et cancer declaré. Intérêt réel ou effet de mode ?. Nutr Clin Metab 19 (2005) 160-165
33. Jatoi A., Rowland K., Loprinzi C.L., Sloan J.A., Dakhil S.R., McDonald N., et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a north central cancer treatment group and national cancer institute of Canada collaborative effort. J Clin Oncol 22 (2003) 2469-2476
34. Fearon K., Barber M.D., Moses A.G., Ahmedzai S.H., Taylor G.S., Tisdale M.J., et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer acchexia. J Clin Oncol 24 (2006) 3401-3407
35. Cerchietti L.C.A., Navigante A.H., and Castro M.A. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. Nutr Cancer 59 (2007) 14-20